These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 26952938)

  • 1. Hypertension, vascular cognitive disorders and neuroprotection.
    Hadjiev D; Mineva P
    Acta Neuropsychiatr; 2007 Oct; 19(5):269-78. PubMed ID: 26952938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive treatment in elderly hypertensives without a history of stroke and the risk of cognitive disorders.
    Hadjiev DI; Mineva PP
    Acta Neurol Scand; 2008 Sep; 118(3):139-45. PubMed ID: 18336621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive treatment with cerebral hemodynamics monitoring by ultrasonography in elderly hypertensives without a history of stroke may prevent or slow down cognitive decline. A pending issue.
    Hadjiev DI; Mineva PP
    Med Hypotheses; 2011 Mar; 76(3):434-7. PubMed ID: 21134723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic influences of azelnidipine, a novel calcium channel blocker, on cerebral circulation in hypertensive patients with ischemic white matter lesions.
    Kimura Y; Kitagawa K; Oku N; Kajimoto K; Kato H; Tanaka M; Sakaguchi M; Hougaku H; Sakoda S; Hatazawa J
    Hypertens Res; 2008 Dec; 31(12):2147-54. PubMed ID: 19139604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertension and cognitive function in the elderly.
    Cherubini A; Lowenthal DT; Paran E; Mecocci P; Williams LS; Senin U
    Am J Ther; 2007; 14(6):533-54. PubMed ID: 18090879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertension and cognitive function in the elderly.
    Cherubini A; Lowenthal DT; Paran E; Mecocci P; Williams LS; Senin U
    Dis Mon; 2010 Mar; 56(3):106-47. PubMed ID: 20189499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting mechanisms of hypertensive vascular disease with dual calcium channel and renin-angiotensin system blockade.
    Weir MR
    J Hum Hypertens; 2007 Oct; 21(10):770-9. PubMed ID: 17597800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium channel blockers and stroke.
    Inzitari D; Poggesi A
    Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):16-30. PubMed ID: 16640170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral small vessel disease, cognitive impairment and vascular dementia.
    Sierra C
    Panminerva Med; 2012 Sep; 54(3):179-88. PubMed ID: 22801435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excessive lowering of blood pressure is not beneficial for progression of brain white matter hyperintensive and cognitive impairment in elderly hypertensive patients: 4-year follow-up study.
    Peng J; Lu F; Wang Z; Zhong M; Sun L; Hu N; Liu Z; Zhang W
    J Am Med Dir Assoc; 2014 Dec; 15(12):904-10. PubMed ID: 25239015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension and dementia.
    Nagai M; Hoshide S; Kario K
    Am J Hypertens; 2010 Feb; 23(2):116-24. PubMed ID: 19927134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive treatments, cognitive decline, and dementia.
    Duron E; Hanon O
    J Alzheimers Dis; 2010; 20(3):903-14. PubMed ID: 20182022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertension in the elderly is associated with white matter lesions and cognitive decline.
    van Swieten JC; Geyskes GG; Derix MM; Peeck BM; Ramos LM; van Latum JC; van Gijn J
    Ann Neurol; 1991 Dec; 30(6):825-30. PubMed ID: 1789694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term safety of antihypertensive therapy.
    Grossman E; Messerli FH
    Prog Cardiovasc Dis; 2006; 49(1):16-25. PubMed ID: 16867847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress in cardiovascular diseases: cognitive function in essential hypertension.
    Birkenhäger WH; Staessen JA
    Prog Cardiovasc Dis; 2006; 49(1):1-10. PubMed ID: 16867845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypertension in the elderly and risk of dementia].
    Hanon O
    Rev Prat; 2010 May; 60(5):649-53. PubMed ID: 20564847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of antihypertensive drug treatment on the risk of dementia and cognitive impairment.
    Poon IO
    Pharmacotherapy; 2008 Mar; 28(3):366-75. PubMed ID: 18294116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of combination of valsartan and amlodipine on salt-induced brain injury in hypertensive rats.
    Dong YF; Kataoka K; Tokutomi Y; Nako H; Nakamura T; Toyama K; Sueta D; Koibuchi N; Yamamoto E; Ogawa H; Kim-Mitsuyama S
    J Pharmacol Exp Ther; 2011 Nov; 339(2):358-66. PubMed ID: 21807884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium channel blockers in cardiovascular pharmacotherapy.
    Godfraind T
    J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):501-15. PubMed ID: 24872348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis signal-regulating kinase 1 is a novel target molecule for cognitive impairment induced by chronic cerebral hypoperfusion.
    Toyama K; Koibuchi N; Uekawa K; Hasegawa Y; Kataoka K; Katayama T; Sueta D; Ma MJ; Nakagawa T; Yasuda O; Tomimoto H; Ichijo H; Ogawa H; Kim-Mitsuyama S
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):616-25. PubMed ID: 24371084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.